Stryker Says Not in Talks to Buy Boston Scientific

Shares of Stryker Corp. (SYK)  shot up in premarket trading on Wednesday, June 13, after the medical technology firm said in an 8-K filing that it wasn't in talks to acquire Boston Scientific Corp. (BSX) .

Stryker's shares jumped nearly 7% to $173.89. Shares of Boston Scientific fell 6.5% to $31.65.

The filing came on the heels of a Wall Street Journal article on Monday stating that Kalamazoo, Mich.-based Stryker had recently made a takeover approach to Marlborough Mass.-based Boston Scientific.

More from Markets

Tesla's Musk Has Serious Dell Envy; Hedge Funds Reveal Portfolio Changes - ICYMI

Tesla's Musk Has Serious Dell Envy; Hedge Funds Reveal Portfolio Changes - ICYMI

Rewind: Jim Cramer on Home Depot, Tapestry, Nordstrom and Square

Rewind: Jim Cramer on Home Depot, Tapestry, Nordstrom and Square

Cardlytics CEO: We Want to Get 5 Out of 5 Payments in the U.S.

Cardlytics CEO: We Want to Get 5 Out of 5 Payments in the U.S.

Stocks Post Solid Gains as Turkey Crisis Stabilizes

Stocks Post Solid Gains as Turkey Crisis Stabilizes

Tesla Competitor Nio Looks to IPO on NYSE

Tesla Competitor Nio Looks to IPO on NYSE